Janus Henderson Group
XERS icon

Janus Henderson Group’s Xeris Biopharma Holdings XERS Stock Holding History

Janus Henderson Group’s Portfolio XERS Stock Details XERS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.71M Buy
295,489
+225,602
+323% +$1.5M ﹤0.01% 1427
2025
Q4 		$548K Hold
69,887
– – ﹤0.01% 1983
2025
Q3 		$569K Buy
+69,887
New +$464K ﹤0.01% 1949

Other funds holding XERS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return
RA
Rosalind Advisors Toronto, Ontario, Canada $249M AUM 80.12% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Janus Henderson Group's XERS Position: Q1 2026 in Review

Janus Henderson Group increased its Xeris Biopharma Holdings (XERS) stake by 323% in Q1 2026, buying an estimated $1.5M and bringing the position to 295,489 shares worth $1.71M. The position accounts for ﹤0.01% of the portfolio, ranked #1427.

Janus Henderson Group first reported a position in XERS in Q3 2025 and has held it in 3 quarters since. 237 funds tracked by Wall St. Rank hold XERS as of Q1 2026.

  • Janus Henderson Group held 295,489 shares of Xeris Biopharma Holdings worth $1.71M as of Q1 2026.
  • Janus Henderson Group bought 225,602 Xeris Biopharma Holdings shares in Q1 2026, an estimated $1.5M.
  • Xeris Biopharma Holdings made up ﹤0.01% of Janus Henderson Group's portfolio in Q1 2026, its #1427 holding.
  • Janus Henderson Group first reported a position in Xeris Biopharma Holdings in Q3 2025 and has held it in 3 quarters since.
  • 237 funds tracked by Wall St. Rank held Xeris Biopharma Holdings as of Q1 2026.

Based on Janus Henderson Group's 13F filing for Q1 2026, filed 15 May 2026.